Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neem leaf powder is a botanical preparation derived from the dried and ground leaves of the neem tree (*Azadirachta indica*), a plant native to the Indian subcontinent. Widely utilized in traditional Ayurvedic, Unani, and Siddha medicine, it contains numerous bioactive compounds, including limonoids (such as azadirachtin), flavonoids, and phenolic acids. Neem leaf powder is investigated for its broad-spectrum antimicrobial, anti-inflammatory, antioxidant, and hypoglycemic properties. In clinical and preclinical studies, it has been evaluated for supporting blood glucose control in type 2 diabetes, managing skin conditions like scabies and eczema, and acting as a natural biopesticide to control agricultural pests such as the cowpea weevil (*Callosobruchus maculatus*).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on neem leaf powder.